Nucleus Software shares market correction, declining approximately 7.6% to trade near ₹690 following a subdued Q1 earnings release

$NUCLEUS The stock is now down 25% year-to-date and has retreated 40% from its 52-week high of ₹1,168. The quarter was characterized by severe margin compression—reaching a four-year low—and persistent top-line contraction, primarily driven by sustained softness in the domestic market and escalating operational costs. Q1 Financial Performance Revenue: The company reported a 3.5% year-over-year (YoY) decline to ₹210.4 crore, marking the second consecutive quarter of top-line contraction. On a sequential basis, revenue fell by 6.4%. Profitability: Net profit contracted by 32.2% YoY to ₹23.9 crore. It is crucial to note that this bottom-line figure was supported by an exceptional gain of ₹9.8 crore, arising from reductions in gratuity and compensated absence liabilities following remuneration structure revisions. Sequentially, net profit dropped 30.9%. Margins: Operating metrics deteriorated sharply. EBITDA plummeted to ₹7.6 crore, with the EBITDA margin compressing by 1,200 basis points to 3.6% (down from 15.6% in the prior year). This is the lowest operational margin recorded since Q1 FY22. Operational Drivers & Segment Dynamics Geographic Headwinds: The core India business, which contributes approximately 55% of total revenues, remained a primary drag, extending its decline for a second consecutive quarter with a 6.4% YoY drop. In contrast, the Middle East portfolio continued to demonstrate resilience and deliver growth. Cost Pressures: Profitability was heavily impacted by an 18% YoY escalation in operating and other expenses, severely restricting the company's operational leverage.